Lindbrook Capital, LLC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 132 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2021$21,000
+10.5%
610
+18.9%
0.00%
-40.0%
Q3 2021$19,000
-5.0%
5130.0%0.01%
+25.0%
Q2 2021$20,000
+17.6%
513
-14.6%
0.00%0.0%
Q1 2021$17,000
-10.5%
6010.0%0.00%
-20.0%
Q4 2020$19,0000.0%601
+0.8%
0.01%0.0%
Q3 2020$19,000
+18.8%
596
+2.9%
0.01%0.0%
Q2 2020$16,000
+128.6%
579
+44.4%
0.01%
+66.7%
Q1 2020$7,0004010.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Karst Peak Capital Ltd 225,000$5,195,00019.07%
AIA Investment Management Private Ltd 354,035$8,175,0003.37%
Bellevue Group AG 440,169$10,164,0000.67%
Prince Street Capital Management LLC 81,400$1,879,0000.46%
PRUDENTIAL PLC 4,112,412$94,956,0000.38%
OppenheimerFunds, Inc. 4,265,943$98,501,0000.14%
Fullerton Fund Management Co Ltd. 9,941$230,0000.13%
SECTORAL ASSET MANAGEMENT INC 31,628$730,0000.10%
SCHRODER INVESTMENT MANAGEMENT GROUP 1,803,955$41,653,0000.08%
Sands Capital Management 830,520$19,177,0000.07%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders